MAPK3 and cancer: In agreement with the findings from our isogenic system, we also observed greater ERK1/2 phosphorylation in MET-addicted cancer cells expressing METΔex14 (Hs746T/H596) vs. wildtype MET-amplified (H1993) cells (Figure 1A).